Novel phosphodiesterase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 491/10 (2006.01) A61K 31/36 (2006.01) A61P 29/00 (2006.01) C07D 493/10 (2006.01) C07D 495/10 (2006.01)

Patent

CA 2676933

The present invention relates to a compound according to formula I, wherein X, A, G, E, R1, R2, R3 are as shown herein; and pharmaceutically acceptable salts, hydrates, N- oxides or solvates hereof, said compounds are used as phoshodiesterase inhibitors in particular PDE4 inhibitors. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g. dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.

La présente invention porte sur un composé représenté par la formule (I), dans laquelle X, A, G, E, R1, R2, R3 sont tels que définis ici; et sur des sels, hydrates, N-oxydes ou solvates pharmaceutiquement acceptables de ce composé. L'invention porte également sur lesdits composés pour une utilisation en thérapie, sur des compositions pharmaceutiques comprenant lesdits composés, sur des procédés de traitement des maladies, par exemple des maladies dermiques, par ledit composé, et sur l'utilisation desdits composés dans la fabrication de médicaments.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel phosphodiesterase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel phosphodiesterase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel phosphodiesterase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1356017

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.